Bigora Sian
Chief Development Officer
Bigora Sian has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: May 19, 2026.
On the most recent filing, Bigora Sian is listed as Chief Development Officer at Processa Pharmaceuticals, Inc. Inside the rolling window, Bigora Sian reported 3 open-market purchases totaling $21K in PCSA and no open-market sales. The largest disclosed transaction in the window is a purchase of 3,957 PCSA shares on Apr 30, 2026, worth $11K.
Companies traded
Other insiders at PCSA
Insider Buying
$21K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bigora Sian made?
Bigora Sian has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Bigora Sian trade?
Bigora Sian has filed SEC Form 4 disclosures for 1 company, including PCSA.
When was Bigora Sian's most recent SEC Form 4 filing?
Bigora Sian's most recent SEC Form 4 filing on Tracefour is dated May 19, 2026.
What is Bigora Sian's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bigora Sian is listed as Chief Development Officer.
What is Bigora Sian's total buy and sell value in the current window?
Inside the rolling retention window, Bigora Sian bought $21K and sold $0 based on SEC Form 4 filings.
What was Bigora Sian's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 3,957 PCSA shares on 2026-04-30, worth $11K, per SEC Form 4 filings.